Guidelines: Consensus Guidelines for COVID-19 Drug Therapies
Guideline Resources
Consensus Guidelines for COVID-19 Drug Therapies
Key Points
No therapies have been approved for tx or prevention of COVID-19. Organizations include NIH, WHO, IDSA (Infect Dis Soc Amer), SCCM (Soc Crit Care Med), ATS (Amer Thoracic Soc), PIDS (Pediatric ID Soc). Refer to source guidelines for methodology and evidence grades. See full table of recommendations.

Access published trial summaries and links to ongoing studies in epocrates’ COVID-19 Tx Trial Updates tool.
Choose Patient Type
Based on multiple guidelines/recommendations from specialty societies/government agencies.
Epocrates Guideline Synopsis Last Update: Sep 17, 2020
Publication Year:
ATSAmerican Thoracic Society
CMACanadian Medical Association
IDSAInfectious Diseases Society of America
NIHNational Institutes of Health
PIDSPediatric Infectious Diseases Society
SCCMSociety of Critical Care Medicine
WHOWorld Health Organization